Dolutegravir use in combination with rifampicin-based tuberculosis therapy: 3 years of real-world experience in a large UK teaching hospital

Muge Cevik*, Hugh McGann

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

3 Citations (Scopus)
Original languageEnglish
Article number420
Number of pages1
JournalSexually Transmitted Infections
Issue number6
Early online date20 Aug 2018
Publication statusPublished - Sept 2018


  • Antiretroviral therapy
  • Audit
  • HIV
  • Infectious diseases
  • Tuberculosis

Cite this